scispace - formally typeset
Journal ArticleDOI

Bioprinting and Cellular Therapies for Type 1 Diabetes

Reads0
Chats0
TLDR
Recent successful attempts to generate β cells are discussed and how this can be coupled with bioprinting technologies in order to fabricate pancreas tissues, which holds great potential for type 1 diabetes.
About
This article is published in Trends in Biotechnology.The article was published on 2017-11-01. It has received 46 citations till now. The article focuses on the topics: 3D bioprinting & Pancreatic islets.

read more

Citations
More filters
Journal ArticleDOI

Small Molecule-Induced Pancreatic β-Like Cell Development: Mechanistic Approaches and Available Strategies.

TL;DR: Basic concepts of pancreatic organogenesis are presented, which intermittently provides a basis for engineering differentiation procedures, mainly based on the use of small molecules, which offer immense benefits in terms of generating efficient functional beta-like cells.
Book ChapterDOI

3D Bioprinting of Cardiovascular Tissue Constructs: Cardiac Bioinks

TL;DR: This chapter explores in depth the parameters that are necessary for a successful bioink solution that can support cardiac tissue structure and function.
Journal ArticleDOI

An insight on advances and applications of 3d bioprinting: A review

TL;DR: A comprehensive overview of different principles and methods employed for 3D bioprinting can be found in this article, focusing mainly on the applications in tissue engineering and regenerative medicine, 3D organ printing and its transplantation, high-throughput screening, drug and toxicology screening, and clinical research.
References
More filters
Journal ArticleDOI

3D bioprinting of tissues and organs

TL;DR: 3D bioprinting is being applied to regenerative medicine to address the need for tissues and organs suitable for transplantation and developing high-throughput 3D-bioprinted tissue models for research, drug discovery and toxicology.
Journal ArticleDOI

Generation of functional human pancreatic β cells in vitro

TL;DR: A scalable differentiation protocol is reported that can generate hundreds of millions of glucose-responsive β cells from hPSC in vitro that secrete human insulin into the serum of mice shortly after transplantation in a glucose-regulated manner, and transplantation of these cells ameliorates hyperglycemia in diabetic mice.
Journal ArticleDOI

3D bioprinting for engineering complex tissues.

TL;DR: Combined with recent advances in human pluripotent stem cell technologies, 3D-bioprinted tissue models could serve as an enabling platform for high-throughput predictive drug screening and more effective regenerative therapies.
Journal ArticleDOI

Three-dimensional bioprinting of thick vascularized tissues.

TL;DR: A multimaterial 3D bioprinting method is reported that enables the creation of thick human tissues (>1 cm) replete with an engineered extracellular matrix, embedded vasculature, and multiple cell types that can be actively perfused for long durations.
Journal ArticleDOI

Type 1 Diabetes Mellitus

TL;DR: A cure is not available, and patients depend on lifelong insulin injections; novel approaches to insulin treatment, such as insulin pumps, continuous glucose monitoring and hybrid closed-loop systems, are in development.
Related Papers (5)